Eosinophils: Provokers or bystanders in asthma?

Clinical and Experimental Allergy Reviews

Volumn 1, Issue 2, 2001, Pages 73-76

  Sampson, A P ^a   Sampson, Tony ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BASOPHIL; BRONCHUS REACTIVITY; CONFERENCE PAPER; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0034893104     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2001.00010.x     Document Type: Conference Paper

References (23)

1. Human eosinophils
2. Mechanisms of eosinophil-associated inflammation
3. Depletion of murine CD4+ T-lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
4. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
5. Allergic networks regulating eosinophilia
6. Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma
7. Eosinophils and asthma: What do measurements tell us?
8. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
9. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma
10. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the asthmatic response
11. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids
12. 4) induces a persistent eosinophilia and airway obstruction which is reversed by regular zafirlukast
13. Antileukotriene therapy: Future directions
14. 5-Lipoxygenase products are necessary for ovalbumin-induced airway res-ponsiveness in mice
15. Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics
16. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings
17. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics
18. 4 in BAL fluid from atopic asthmatics after endobronchial allergen challenge
19. 4 synthase in bronchial biopsies of aspirin-intolerant asthmatics
20. Seasonal allergen exposure increases expression of leukotriene pathway enzymes and induces eosinophil influx in bronchial mucosa of atopic asthmatics
21. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils
22. 4 generation through contact with bronchial epithelial cells
23. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals